Mechanism and structure based design of inhibitors of AMP and adenosine deaminase

Bioorg Med Chem. 2021 Aug 1:43:116272. doi: 10.1016/j.bmc.2021.116272. Epub 2021 Jun 10.

Abstract

Inhibitors of the enzyme adenosine monophosphate deaminase (AMPD) show interesting levels of herbicidal activity. An enzyme mechanism-based approach has been used to design new inhibitors of AMPD starting from nebularine (6) and resulting in the synthesis of 2-deoxy isonebularine (16). This compound is a potent inhibitor of the related enzyme adenosine deaminase (ADA; IC50 16 nM), binding over 5000 times more strongly than nebularine. It is proposed that the herbicidal activity of compound 16 is due to 5́-phosphorylation in planta to give an inhibitor of AMPD. Subsequently, an enzyme structure-based approach was used to design new non-ribosyl AMPD inhibitors. The initial lead structure was discovered by in silico screening of a virtual library against plant AMPD. In a second step, binding to AMPD was further optimised via more detailed molecular modeling leading to 2-(benzyloxy)-5-(imidazo[2,1-f][1,2,4]triazin-7-yl)benzoic acid (36) (IC50 300 nM). This compound does not inhibit ADA and shows excellent selectivity for plant over human AMPD.

MeSH terms

  • AMP Deaminase / antagonists & inhibitors*
  • AMP Deaminase / metabolism
  • Adenosine Deaminase / metabolism*
  • Adenosine Deaminase Inhibitors / chemical synthesis
  • Adenosine Deaminase Inhibitors / chemistry
  • Adenosine Deaminase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Humans
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Adenosine Deaminase Inhibitors
  • Adenosine Deaminase
  • AMP Deaminase